AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Ziglip-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Prochem Bioceuticals Pvt. Ltd.

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Ziglip-M 50/500 Tablet

Diabex Duo 50/500 tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action mitigates the risk of severe diabetic complications, such as renal impairment and vision loss, and may lessen the probability of cardiovascular events. Diabex Duo 50/500 may be administered independently or in conjunction with other antidiabetic therapies. Optimal efficacy is achieved through adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health status, blood sugar readings, and concurrent medications. Ingesting the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; cessation should only occur under medical supervision. Effective blood sugar control prevents future complications. Maintaining the prescribed diet and exercise regimen is crucial. Lifestyle modifications significantly influence diabetes management. Potential side effects include, but are not limited to: diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a possibility when used with insulin or sulfonylureas; understanding its symptoms and management is essential. This medication isn't suitable for everyone. Prior to commencing treatment, inform your physician about any pre-existing renal, hepatic, or cardiac conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Interactions with other medications are possible; provide a complete medication list to your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout the treatment period.

Primary Ingredients of Ziglip-M 50/500 Tablet

No text provided to rephrase.

Uses of Ziglip-M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Ziglip-M 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ziglip-M 50/500 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Ziglip-M 50/500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Ziglip-M 50/500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Ziglip-M 50/500 Tablet should be administered with food.

How Ziglip-M 50/500 Tablet works:

The dual-action tablet, Ziglip-M 50/500, combines two medications to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Ziglip-M 50/500 Tablet use is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ziglip-M 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Ziglip-M 50/500 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Ziglip-M 50/500 Tablets. Dosage modifications for Ziglip-M 50/500 Tablets may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Patients with liver disease should likely avoid Ziglip-M 50/500 Tablets due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Ziglip-M 50/500 Tablet :

Should you forget to take your Ziglip-M 50/500 Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Ziglip-M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Ziglip-M 50/500 Tablet

Ziglip-M 50/500 Tablets rarely cause hypoglycemia by themselves, but insufficient caloric intake while using them can. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Ziglip-M 50/500 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Ziglip-M 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Ziglip-M 50/500 tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Ziglip-M 50/500 Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Ziglip-M 50/500 and seek immediate medical attention.
Prolonged use of Ziglip-M 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Ziglip-M 50/500 Tablet as directed by your doctor is safe. However, even with proper dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if using insulin or sulphonylurea) may occur. Report any persistent side effects to your doctor.
Ziglip-M 50/500 Tablet
114
MRP 132
13% off